Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HTWO is a consumer health and wellness company that specializes in the production of hydrogen-infused water designed to reduce oxidative stress and improve metabolic health. Founded by Dr. Cody Cook, a scientist with a background in molecular biology and oncology, the company leverages the antioxidant properties of molecular hydrogen (H2) to target cellular inflammation and enhance physical recovery. HTWO's flagship product is a hydrogen-rich beverage packaged in specialized pouches to maintain gas concentration. The company's approach is rooted in clinical research exploring the benefits of hydrogen gas for metabolic syndrome, athletic performance, and general cellular health. HTWO operates at the intersection of the beverage industry and functional medicine, providing a non-pharmacological intervention for oxidative damage.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HTWO HydrogenWater.